BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21292776)

  • 1. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
    Bishton MJ; Harrison SJ; Martin BP; McLaughlin N; James C; Josefsson EC; Henley KJ; Kile BT; Prince HM; Johnstone RW
    Blood; 2011 Mar; 117(13):3658-68. PubMed ID: 21292776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide.
    Bishton MJ; Gardiner EE; Harrison SJ; Prince HM; Johnstone RW
    Thromb Res; 2013 Jun; 131(6):514-20. PubMed ID: 23642854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
    Machlus KR; Wu SK; Vijey P; Soussou TS; Liu ZJ; Shacham E; Unger TJ; Kashyap T; Klebanov B; Sola-Visner M; Crochiere M; Italiano JE; Landesman Y
    Blood; 2017 Aug; 130(9):1132-1143. PubMed ID: 28630120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDACI-induced thrombocytopenia is caused by its unexpected target.
    Kitamura T; Inoue D
    Exp Hematol; 2012 Sep; 40(9):695-7. PubMed ID: 22771790
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms.
    Ali A; Bluteau O; Messaoudi K; Palazzo A; Boukour S; Lordier L; Lecluse Y; Rameau P; Kraus-Berthier L; Jacquet-Bescond A; Lelièvre H; Depil S; Dessen P; Solary E; Raslova H; Vainchenker W; Plo I; Debili N
    Cell Death Dis; 2013 Jul; 4(7):e738. PubMed ID: 23887629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panobinostat (LBH589)-induced acetylation of tubulin impairs megakaryocyte maturation and platelet formation.
    Iancu-Rubin C; Gajzer D; Mosoyan G; Feller F; Mascarenhas J; Hoffman R
    Exp Hematol; 2012 Jul; 40(7):564-74. PubMed ID: 22381681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
    Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
    Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.
    Simic D; Sang N
    Exp Hematol; 2019 Apr; 72():36-46. PubMed ID: 30611870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4.
    Golfier S; Kondo S; Schulze T; Takeuchi T; Vassileva G; Achtman AH; Gräler MH; Abbondanzo SJ; Wiekowski M; Kremmer E; Endo Y; Lira SA; Bacon KB; Lipp M
    FASEB J; 2010 Dec; 24(12):4701-10. PubMed ID: 20686109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant interleukin-6 and thrombopoietin on isolated guinea pig bone marrow megakaryocyte protein phosphorylation and proplatelet formation.
    Leven RM; Clark B; Tablin F
    Blood Cells Mol Dis; 1997 Aug; 23(2):252-68. PubMed ID: 9410469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.
    Pleines I; Dütting S; Cherpokova D; Eckly A; Meyer I; Morowski M; Krohne G; Schulze H; Gachet C; Debili N; Brakebusch C; Nieswandt B
    Blood; 2013 Oct; 122(18):3178-87. PubMed ID: 23861250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proplatelet formation is regulated by the Rho/ROCK pathway.
    Chang Y; Auradé F; Larbret F; Zhang Y; Le Couedic JP; Momeux L; Larghero J; Bertoglio J; Louache F; Cramer E; Vainchenker W; Debili N
    Blood; 2007 May; 109(10):4229-36. PubMed ID: 17244674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
    Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
    Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
    Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
    Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
    Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
    Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.